Protalix Biotherapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $67k | 30k | 2.22 |
| 2025-03-31 | $4.1k | 1.6k | 2.56 |
| 2024-12-31 | $3.0k | 1.6k | 1.88 |
| 2024-09-30 | $1.6k | 1.6k | 1.02 |
| 2024-06-30 | $1.9k | 1.6k | 1.17 |
| 2024-03-31 | $41k | 33k | 1.26 |
| 2023-12-31 | $78k | 44k | 1.78 |
| 2023-09-30 | $73k | 44k | 1.66 |
| 2023-06-30 | $90k | 45k | 2.00 |
| 2022-06-30 | $0 | 395 | 0.00 |
| 2022-03-31 | $999 | 1.1k | 0.89 |
| 2021-03-31 | $6.0k | 1.3k | 4.64 |
| 2020-12-31 | $8.0k | 2.1k | 3.81 |
| 2020-09-30 | $8.0k | 2.1k | 3.81 |
| 2020-06-30 | $0 | 100 | 0.00 |
| 2019-12-31 | $0 | 100 | 0.00 |